Multiple Serotonin Receptors: Opportunities for New Treatments for Obesity?-Reference-Cited by-同舟云学术

Multiple Serotonin Receptors: Opportunities for New Treatments for Obesity?

Published:1995-11 Issue:S4 Volume:3 Page:449S-462S
ISSN:1071-7323
Container-title:Obesity Research
language:en
Short-container-title:

Author:

Dourish Colin T.

Publisher

Wiley

Subject

Public Health, Environmental and Occupational Health,Endocrinology,Endocrinology, Diabetes and Metabolism,Food Science,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/j.1550-8528.1995.tb00212.x/fullpdf

Reference108 articles.

1. Cholecystokinin elicits the complete behavioural sequence of satiety in rats;Antin;J Comp Physiol Psychol.,1975

2. 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) elicits feeding in free feeding rats by acting on central serotonin neurons;Bendotti;Eur J Pharmacol.,1986

3. The role of putative 5-HT1A and 5-HT1B receptors in the control of feeding in rats;Bendotti;Life Sci.,1987

4. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects;Bjork;J Pharmacol Exp Ther.,1991

5. Is there a role for 5-hydroxytryptamine in feeding;Blundell;Int J Obes.,1977

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibitory control mediates the effect of high intensity interval exercise on food choice;Appetite;2024-09

2. Utility of an experimental medicine model to evaluate efficacy, side-effects and mechanism of action of novel treatments for obesity and binge-eating disorder;Appetite;2022-09

3. Lisdexamfetamine and binge-eating disorder: A systematic review and meta-analysis of the preclinical and clinical data with a focus on mechanism of drug action in treating the disorder;European Neuropsychopharmacology;2021-12

4. Interactions between metabolic, reward and cognitive processes in appetite control: Implications for novel weight management therapies;Journal of Psychopharmacology;2017-10-26

5. Preclinical Toxicology of Vaccines 1 1Disclaimer: The findings and conclusions in this chapter have not been formally disseminated by the Food and Drug Administration and should not be construed to represent any Agency determination or policy.;A Comprehensive Guide to Toxicology in Nonclinical Drug Development;2017